Target
Enoyl-[acyl-carrier-protein] reductase [NADPH] FabI
Ligand
BDBM36542
Substrate
n/a
Meas. Tech.
Tight-binding assay
pH
7.5±n/a
Ki
494±40.2 nM
Comments
extracted
Citation
 Tonge, PPan, P Pyridone FabI inhibitors and uses thereof US Patent  US10071965 Publication Date 9/11/2018 
Target
Name:
Enoyl-[acyl-carrier-protein] reductase [NADPH] FabI
Synonyms:
Enoyl-ACP Reductase (FabI) | Enoyl-[acyl-carrier-protein] reductase [NADPH] FabI | FABI_STAAR | NADPH-dependent enoyl-ACP reductase | fabI | trans-2-enoyl-[acyl carrier protein] reductase
Type:
Enzyme
Mol. Mass.:
27989.00
Organism:
Staphylococcus aureus
Description:
Q6GI75
Residue:
256
Sequence:
MLNLENKTYVIMGIANKRSIAFGVAKVLDQLGAKLVFTYRKERSRKELEKLLEQLNQPEAHLYQIDVQSDEEVINGFEQIGKDVGNIDGVYHSIAFANMEDLRGRFSETSREGFLLAQDISSYSLTIVAHEAKKLMPEGGSIVATTYLGGEFAVQNYNVMGVAKASLEANVKYLALDLGPDNIRVNAISAGPIRTLSAKGVGGFNTILKEIEERAPLKRNVDQVEVGKTAAYLLSDLSSGVTGENIHVDSGFHAIK
  
Inhibitor
Name:
BDBM36542
Synonyms:
5-methyl-2-phenoxylphenol | PT53 | US10071965, Compound PT53
Type:
Small organic molecule
Emp. Form.:
C13H12O2
Mol. Mass.:
200.2332
SMILES:
Cc1ccc(Oc2ccccc2)c(O)c1
Structure:
Search PDB for entries with ligand similarity: